Physician profile
David G Rubin
NPI 1013160209
$14,239.44
in general payments reported to CMS, 2019-2025
15 companies · $4,505 in 2025
The $4,505 reported for 2025 was more than what 79% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $839 · 2020: $1,505 · 2021: $1,085 · 2022: $2,067 · 2023: $3,510 · 2024: $728 · 2025: $4,505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $7,074 · Food and Beverage: $1,546 · Travel and Lodging: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $7,073.98 |
| Food and Beverage | $1,545.85 |
| Travel and Lodging | $123.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurora Spine, INC. | $8,841.50 | 2022-2025 | Discovery Tinano Acif |
| Medacta USA, INC. | $1,841.13 | 2020-2025 | Gmk Sphere |
| Stryker Corporation | $1,337.64 | 2019-2024 | Gamma, Hydroset |
| Boston Scientific Corporation | $509.97 | 2019-2021 | |
| Pylant Medical | $339.71 | 2024-2025 | |
| Corelink, LLC | $289.12 | 2019-2021 | |
| Medtronic USA, INC. | $204.17 | 2019-2020 | |
| Nevro Corp. | $202.86 | 2020 | |
| Wenzel Spine, INC. | $163.24 | 2025 | Varilift |
| Globus Medical, INC. | $158.33 | 2024 | Precice Intramedullary Limb Lengthening System |
| Nuvasive, INC. | $125.54 | 2019 | |
| Medtronic, INC. | $121.02 | 2021 | |
| Cerapedics INC. | $75.25 | 2020 | |
| Next Science LLC | $17.72 | 2023 | Surgx, Xperience, Blastx |
| Integra Lifesciences Corporation | $12.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.